Obsessive-Compulsive Disorder (OCD) Clinical Trials

Find Obsessive-Compulsive Disorder (OCD) Clinical Trials Near You

Effects of Aerobic Exercise on Obsessive-Compulsive Disorder Symptoms and Cognitive Flexibility

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to examine the acute effects of exercise on cognitive flexibility and symptom reactivity. The main questions it aims to answer are: Does moderate intensity physical activity reduce subjective distress, compulsive urges, and intrusions- and increase cognitive flexibility- in adults with obsessive-compulsive disorder compared to low-intensity physical activity? Researchers will compare low- to moderate-intensity exercise to see if moderate physical activity increases cognitive flexibility and reduces symptom reactivity in adults with obsessive-compulsive disorder (OCD). Participants will: Complete self-report surveys, psychiatric interviews, and cognitive tasks. Be assigned to either a low- or moderate-intensity exercise condition and complete physical activity. Repeat cognitive and symptom measures following the exercise intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 64
Healthy Volunteers: f
View:

• Adults, age 18 to 64 years

• Meet diagnostic criteria for OCD (per the DIAMOND)

• Stable psychiatric or medication treatment (if ≥4-weeks), or if no active treatment. Psychotropic medications will be reviewed with the study psychiatrist on a case by case basis.

Locations
United States
Connecticut
Temple Medical Center
RECRUITING
New Haven
Contact Information
Primary
Emily Weiss, PhD
emily.weiss@yale.edu
203-858-1225
Time Frame
Start Date: 2026-02-16
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 50
Treatments
Experimental: Moderate-Intensity Exercise
Other: Low-Intensity Exercise
Control
Related Therapeutic Areas
Sponsors
Leads: Yale University

This content was sourced from clinicaltrials.gov